Tag: arrhythmia monitoring
HeartBeam receives US FDA clearance for at-home arrhythmia assessment with cable-free...
HeartBeam has announced that the US Food and Drug Administration (FDA) has granted 510(k) clearance for the company’s “groundbreaking” 12-lead electrocardiogram (ECG) synthesis software...
HeartBeam announces US FDA clearance for at-home, high-fidelity heart monitoring technology
HeartBeam has announced that the US Food and Drug Administration (FDA) has granted 510(k) clearance of the HeartBeam system for comprehensive arrhythmia assessment. A...
Two innovative ECG monitors obtain new US FDA clearances
Two innovative electrocardiogram (ECG) products have gained new US Food and Drug Administration (FDA) clearances for monitoring cardiac arrhythmias—Fourth Frontier’s Frontier X Plus (FX+)...

